Sumatriptan changed migraine care when the FDA approved it as Imitrex at the end of 1992: it was the first drug designed specifically to stop a migraine attack. More than thirty years later it is still a cornerstone, and it still fails for a lot of people. Studies find that roughly a third of people get an inadequate response from triptans, and about one in five cannot take them for medical reasons. If sumatriptan is not working for you, the reasons are often fixable, failing one triptan does not mean failing them all, and there are now entire drug classes, and clinical trials, built for people in your position.
Looking for treatment options for Migraine?
Browse open clinical trials near you! We'll handle the follow-up.
Signs sumatriptan is not working
Headache specialists usually judge an acute migraine medicine by what happens two hours after taking it: is the pain gone or reduced to mild, and are you able to function? A medicine is considered to be working if it does that in most attacks, roughly three out of four. Sumatriptan is not working if the pain is still moderate or severe at two hours in most attacks, if relief comes but the migraine returns within a day, if side effects such as chest tightness, tingling, or fatigue are worse than the headache, or if you need it so often that it causes more headaches. The Imitrex label itself notes that if a patient does not respond to the first attack treated, the diagnosis should be reconsidered, because not every severe headache is migraine.
Why triptans fail
Taken too late. Triptans work best early in an attack, while pain is still mild. Many people wait to see whether a headache becomes a migraine, and by then the drug has less to work with.
The wrong form. Nausea and vomiting slow absorption of a tablet, or bring it straight back up. Sumatriptan also comes as a nasal spray and an injection; in trials of the 6 mg injection, relief began as early as 10 minutes after the dose.
The wrong triptan for you. There are seven triptans, and they differ in speed and duration. Response to one does not predict response to another, which is why headache guidelines do not call someone triptan resistant until at least two different triptans have failed.
Medication overuse headache. Taking triptans on 10 or more days a month, or some other acute migraine drugs, can make headaches more frequent, a warning printed on every Imitrex label. If you are reaching for sumatriptan most days, the medicine may be part of the problem.
It is not only migraine. Tension type headache, headaches from sleep apnea, and other causes do not respond to triptans in the same way.
What doctors usually try next
The usual first steps are practical: take the triptan earlier in the attack, switch to a nasal spray or injection if nausea is involved, add an anti inflammatory pain reliever, or try a different triptan. If two triptans have not worked or cannot be taken, the next options are newer drug classes. Gepants, such as ubrogepant (Ubrelvy) and rimegepant (Nurtec), block a migraine signaling protein called CGRP and were approved in 2019 and 2020; a nasal gepant followed in 2023. Ditans, such as lasmiditan, act on a different serotonin receptor without narrowing blood vessels, which matters for people with heart disease who cannot take triptans. And if attacks are frequent, the more important change is usually adding prevention, a daily or monthly treatment that reduces how often attacks happen, so that acute medicine is needed less. Our migraine treatment guide covers each class; your own clinician should guide the choice.
Nurtec or Ubrelvy not working either?
Gepants are newer, but they do not work for everyone, and post hoc analyses suggest they work about as well in people who did not respond to triptans as in those who did. If both triptans and gepants are falling short, the conversation usually moves to prevention: monthly CGRP antibody injections, a daily gepant taken for prevention, botulinum toxin injections for chronic migraine, or older preventive medicines. People who have failed several preventive treatments are exactly the group many current migraine trials are designed for. Our guide to chronic migraine explains when headaches become chronic and what changes in treatment.
Trials designed for people whose migraine medicine is not working
Migraine research has moved fast since the first CGRP drugs, and dozens of trials are recruiting in the US. Many focus on prevention for people whose attacks are frequent or not controlled by current treatment: new oral medicines, botulinum toxin products, gepants studied for chronic migraine, and procedures for migraine that has not responded to anything. Most are placebo controlled, so not every participant receives the study treatment, and many allow you to keep your current acute medicine during the study.
Studies recruiting now for exactly this situation
A Phase 3 trial of rimegepant for preventing chronic migraine enrolls adults with chronic migraine at 11 US sites. A Phase 3 trial of Xeomin injections for preventing chronic migraine runs at 48 US sites, with a related trial for episodic migraine. For migraine that has not responded to standard treatment, a device study tests blocking a small artery in the lining of the brain in adults with refractory chronic migraine. Each listing spells out which prior treatments are allowed, and applying takes about 5 minutes. More are on our migraine clinical trials page.
Common questions
Why is sumatriptan not working? The most common reasons are taking it too late in the attack, nausea preventing absorption of the tablet, the particular triptan not suiting you, or medication overuse headache from taking acute medicines on 10 or more days a month. Sometimes the headache is not migraine at all.
If Imitrex does not work, will other triptans fail too? Not necessarily. Response to one triptan does not predict response to another, which is why guidelines define triptan failure only after at least two different triptans. In one German registry, about 43 percent of patients had failed one triptan but only 13 percent had failed two or more.
What can I take if triptans don't work for me? Options a clinician may consider include a different triptan or form, adding an anti inflammatory, gepants such as Ubrelvy or Nurtec, a ditan, and, if attacks are frequent, preventive treatment. Clinical trials are testing additional options.
What should I do if a migraine won't go away? A migraine lasting more than 72 hours is called status migrainosus and needs medical care, often in urgent care or an emergency department. Get help right away for a sudden severe headache, a headache with fever, stiff neck, confusion, weakness, or vision loss, or the worst headache of your life.
See migraine clinical trials recruiting now
Browse open studies, filter by location, and apply in about 5 minutes: Migraine Clinical Trials